Search

Your search keyword '"VERONESI, ELENA"' showing total 192 results

Search Constraints

Start Over You searched for: Author "VERONESI, ELENA" Remove constraint Author: "VERONESI, ELENA"
192 results on '"VERONESI, ELENA"'

Search Results

1. Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma

4. Early efficacy evaluation of mesenchymal stromal cells (MSC) combined to biomaterials to treat long bone non-unions

7. Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial

8. Novel bioprinted 3D model to human fibrosis investigation

14. Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer

15. Supplementary Figure 2 from Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy

16. Supplementary Figure 1 from Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy

17. Data from Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy

18. Supplementary Figure 3 from Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy

19. Supplementary Figure 5 from Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy

20. Supplementary Materials and Methods, Figure Legends 1-5 from Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy

21. Supplementary Figure 4 from Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy

22. A new strategy to prevent biofilm and clot formation in medical devices: The use of atmospheric non-thermal plasma assisted deposition of silver-based nanostructured coatings

23. MSC and Tumors: Homing, Differentiation, and Secretion Influence Therapeutic Potential

24. Autologous Marrow Mesenchymal Stem Cell Driving Bone Regeneration in a Rabbit Model of Femoral Head Osteonecrosis

25. Human Adipose Mesenchymal Stromal/Stem Cells Improve Fat Transplantation Performance

32. TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma

34. Additional file 1 of Microfragmented adipose tissue is associated with improved ex vivo performance linked to HOXB7 and b-FGF expression

35. Additional file 2 of Microfragmented adipose tissue is associated with improved ex vivo performance linked to HOXB7 and b-FGF expression

36. Assessing Biocompatibility of Face Mask Materials during COVID-19 Pandemic by a Rapid Multi-Assays Strategy

38. Testing Surgical Face Masks in an Emergency Context: The Experience of Italian Laboratories during the COVID-19 Pandemic Crisis

45. MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic Adenocarcinoma

48. Transportation Conditions for Prompt Use of Ex-vivo Expanded and Freshly Harvested Clinical Grade Bone Marrow MSC For Bone Regeneration

50. Potency Biomarker Signature Genes from Multiparametric Osteogenesis Assays: Will cGMP Human Bone Marrow Mesenchymal Stromal Cells Make Bone?

Catalog

Books, media, physical & digital resources